US EditionPublished • loading... • Updated
Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
Summary by Arizona Daily Sun
23 Articles
23 Articles
The Union Democrat+22 Reposted by 22 other sources
Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
– Event to be webcast live on Thursday, October 23, 2025 at 1:30 p.m. PT –
Coverage Details
Total News Sources23
Leaning Left1Leaning Right0Center10Last UpdatedBias Distribution91% Center
Bias Distribution
- 91% of the sources are Center
91% Center
C 91%
Factuality
To view factuality data please Upgrade to Premium
